Search / Trial NCT06230731

Oxygenation in Vascular Lesions of the Colon

Launched by UNIVERSITY OF CHICAGO · Jan 19, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how well oxygen is delivered to certain areas of the colon in people with vascular lesions, which are abnormal blood vessel growths. The study aims to understand the oxygen levels in the proximal colon, which is the part of the colon closest to the small intestine. The trial is currently recruiting participants aged between 18 and 89 who are scheduled for a routine colonoscopy and have either a history of vascular lesions in the colon or a healthy colon.

To join the study, participants must be within the specified age range and have a standard colonoscopy scheduled. However, those under 18, over 90, or with certain medical conditions, such as specific ulcers or previous colon surgeries, will not be eligible. If you decide to participate, you can expect to undergo normal procedures related to your colonoscopy while contributing to important research that could help improve the understanding of vascular lesions in the colon.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Undergo standard of care colonoscopy
  • People with a history of vascular lesions of the colon
  • People with healthy colon
  • 18 - 89 years of age
  • Exclusion Criteria:
  • Age \< 18 years
  • Age \> 90 years
  • People with ulcerations in at ascending colon opposite the ileocecal valve
  • Previous colon surgery

Trial Officials

Joel Pekow, MD

Principal Investigator

University of Chicago

About University Of Chicago

The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.

Locations

Chicago, Illinois, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0